Order Article Reprints

Sacco R, Giannini EG, Tortora R, Di Costanzo GG, Mega A, Marzi L, Pieri G, Pasta A, Daniele B, Federico P, et al. Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis. Cancers. 2025; 17(11):1808. https://doi.org/10.3390/cancers17111808

Sacco, Rodolfo, Edoardo G. Giannini, Raffaella Tortora, Giovan Giuseppe Di Costanzo, Andrea Mega, Luca Marzi, Giulia Pieri, Andrea Pasta, Bruno Daniele, Piera Federico, and et al. 2025. "Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis" Cancers 17, no. 11: 1808. https://doi.org/10.3390/cancers17111808

Sacco, R., Giannini, E. G., Tortora, R., Di Costanzo, G. G., Mega, A., Marzi, L., Pieri, G., Pasta, A., Daniele, B., Federico, P., Cabibbo, G., Russello, M., Cocuzza, C., Giacomelli, L., Silletta, M., Gallo, P., Gentilucci, U. V., Casadei-Gardini, A., Claar, E., ... Facciorusso, A., on behalf of the A.I.G.O. (Italian Association of Hospital Gastroenterologists) and C.L.E.O. (Italian Association of Hospital Hepatologists) . (2025). Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis. Cancers, 17(11), 1808. https://doi.org/10.3390/cancers17111808